Harvard Bioscience (HBIO) Posts Q3 EPS of $0.04, Down Y/Y

November 4, 2009 4:54 PM EST

Harvard Bioscience Inc. (NASDAQ: HBIO) reports Q3 EPS of $0.04, compared to $0.05 in the same quarter last year. Revenue for the quarter was $21 million, versus $20 million in Q08.


Related Categories

Earnings

Stocks Mentioned

HBIO 3.65

-0.02 -0.54%
Volume: 49,884
Track HBIO


Add Your Comment